Obinutuzumab plus chlorambucil cost effective in untreated CLL

Becker U, et al. Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy. Value in Health 19: 374-82, No. 4, Jun 2016. Available from: URL: http://doi.org/10.1016/j.jval.2015.12.018 CrossRefPubMedGoogle Scholar